These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

93 related items for PubMed ID: 5530599

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Voided urine fluorescence in situ hybridization testing for upper tract urothelial carcinoma surveillance.
    Johannes JR, Nelson E, Bibbo M, Bagley DH.
    J Urol; 2010 Sep; 184(3):879-82. PubMed ID: 20643443
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Cytological study of the urine in tumors of the kidneys, renal pelvis and bladder].
    Enokhovich VA.
    Lab Delo; 1979 Sep; (3):150-5. PubMed ID: 85762
    [No Abstract] [Full Text] [Related]

  • 6. Exfoliative cytology in urine.
    Tsai SY, Laughlin VC, Goodsitt E, Basa A.
    J Urol; 1968 Mar; 99(3):342-4. PubMed ID: 4869567
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Role of cytology in the diagnosis, management and follow-up of genito-urinary malignancy.
    Singh SM, Mathur BB, Wadhwa SN, Verma K.
    Indian J Cancer; 1980 Dec; 17(4):226-9. PubMed ID: 7228105
    [No Abstract] [Full Text] [Related]

  • 9. Rapid urinary cytology by phase contrast microscopy. A preliminary report.
    de Voogt HJ.
    Urol Res; 1973 Oct; 1(3):113-9. PubMed ID: 4612922
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Clinical study of urine NMP 22 (nuclear matrix protein 22) as a tumor marker in urinary epithelial cancer.
    Takeuchi Y, Sawada Y, Yabuki D, Masuda E, Satou D, Kuroda K, Tajima M, Sawamura Y, Matsushima M.
    Aktuelle Urol; 2003 Jul; 34(4):265-6. PubMed ID: 14566681
    [Abstract] [Full Text] [Related]

  • 13. The value of upper tract cytology after transurethral resection of bladder tumor in patients with bladder transitional cell cancer.
    Sadek S, Soloway MS, Hook S, Civantos F.
    J Urol; 1999 Jan; 161(1):77-9; discussion 79-80. PubMed ID: 10037373
    [Abstract] [Full Text] [Related]

  • 14. Initial evaluation of the diagnostic performance of the new urinary bladder cancer antigen test as a tumor marker for transitional cell carcinoma of the bladder.
    Sánchez-Carbayo M, Herrero E, Megias J, Mira A, Espasa A, Chinchilla V, Soria F.
    J Urol; 1999 Apr; 161(4):1110-5. PubMed ID: 10081849
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Fluorescence in situ hybridization for detecting upper urinary tract tumors--a preliminary report.
    Akkad T, Brunner A, Pallwein L, Gozzi C, Bartsch G, Mikuz G, Steiner H, Verdorfer I.
    Urology; 2007 Oct; 70(4):753-7. PubMed ID: 17991550
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Survivin mRNA expression in urine as a biomarker for patients with transitional cell carcinoma of bladder.
    Hou JQ, He J, Wen DG, Chen ZX, Zeng J.
    Chin Med J (Engl); 2006 Jul 05; 119(13):1118-20. PubMed ID: 16834932
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.